Andrew Guggenhime's Net Worth

Andrew Guggenhime's net worth is estimated to be at least $6,432,443.00 as of 06/14/2024. CoreStreet's estimation of Andrew Guggenhime's net worth is based on their sale of stock and current holding of stock.

Andrew Guggenhime is CFO at Vaxcyte Inc. They have executed at least 22 trades of stock as per SEC Form 4 filings. Their most recent trade was for 8,000 units of PCVX stock on 05/20/2024. Their biggest sale was on 05/20/2024 when they sold 8,000 units of Vaxcyte Inc stock for $599,920.00. They typically trade 4 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $6,432,443.00
Most recent insider trade:
  • May 20, 2024

Andrew Guggenhime's Insider Trading History

Vaxcyte IncTitleAmountPriceTypeTotal Value
May 20, 2024
CFO8,000$74.99Sell$599,920.00
April 18, 2024
CFO8,000$61.27Sell$490,160.00
March 18, 2024
CFO8,000$69.02Sell$552,160.00
Jan. 18, 2024
CFO8,000$60.73Sell$485,840.00
Dec. 18, 2023
CFO8,000$60.18Sell$481,440.00
Nov. 20, 2023
CFO8,000$51.13Sell$409,040.00
Oct. 18, 2023
CFO8,000$45.91Sell$367,280.00
Sept. 19, 2022
CFO3,100$26.10Sell$80,910.00
Aug. 29, 2022
CFO17,653$28.00Sell$494,284.00
Aug. 26, 2022
CFO1,295$28.00Sell$36,260.00
Aug. 18, 2022
CFO3,100$25.26Sell$78,306.00
July 18, 2022
CFO3,100$24.53Sell$76,043.00
May 18, 2022
CFO3,100$24.44Sell$75,764.00
April 18, 2022
CFO3,100$24.05Sell$74,555.00
Dec. 23, 2021
CFO3,100$24.00Sell$74,400.00
Nov. 18, 2021
CFO3,100$24.53Sell$76,043.00
Journey Medical Corporation Common StockTitleAmountPriceTypeTotal Value
Nov. 9, 2016
CFO4,100$35.02Sell$143,582.00
Oct. 11, 2016
CFO10,900$34.34Sell$374,306.00
Sept. 19, 2016
CFO15,000$35.01Sell$525,150.00
Sept. 12, 2016
CFO10,000$32.53Sell$325,300.00
Aug. 11, 2016
CFO10,000$31.02Sell$310,200.00
July 11, 2016
CFO10,000$30.15Sell$301,500.00